InvestSMART

Enlitic Inc (ASX:ENL)

ALERT: Price-sensitive ASX Announcement for ENL
Current share price for ENL : $0.004 -0.003 (-42.86%)+
Announcement
Release
1 Apr 2026 9:17AM
Price at Release
$0.007
Full Release
download
Summary
Enlitic Inc has secured a US$1.2 million contract with Parkland Health for the migration and standardization of approximately 9 million legacy imaging studies using its AI-powered platform, Ensight. This contract represents a significant step in enhancing data integrity and interoperability in the healthcare system, with the potential to expand to 13 million studies. Approximately 90% of the contract's revenue is anticipated within the calendar year, reflecting Enlitic's growing momentum in the US healthcare market. The contract is part of a series of significant agreements Enlitic has signed recently, underscoring the company's capabilities in delivering large-scale, complex imaging projects.
Key Points
  • Enlitic, Inc. announced a US$1.2 million contract with Parkland Health for imaging data migration.
  • The contract involves migrating and standardizing approximately 9 million legacy imaging studies.
  • Enlitic's AI-powered platform, Ensight, will be utilized for data standardization during the migration.
  • The contract has expansion potential to cover up to 13 million imaging studies.
  • Approximately 90% of the contract's revenue is expected to be realized within the current calendar year.
  • This is the third significant contract signed by Enlitic in March 2026, with a combined value of US$2.95 million.
  • The project aims to enhance data integrity and interoperability in the healthcare system.
  • Enlitic's CEO highlighted the validation of their capabilities through this competitive contract award.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.